Risk of hepatocellular carcinoma among individuals with different aetiologies of cirrhosis: a population-based cohort study

QR Code

Risk of hepatocellular carcinoma among individuals with different aetiologies of cirrhosis: a population-based cohort study

Background: Among patients with cirrhosis, only those determined to be at risk for hepatocellular carcinoma (HCC) should undergo surveillance. However, little is known about how different aetiologies of cirrhosis affect risk for HCC. Aim: To quantify the cumulative incidence of HCC among a represen...

Full description

Bibliographic Details
Main Authors:	West, Joe, Card, Timothy R., Aithal, Guruprasad P., Fleming, Kate M.
Format:	Article
Published:	Wiley 2017
Subjects:	Epidemiology; Cancer; Cirrhosis; Hepatocellular carcinoma; Incidence; Alcohol; Cryptogenic; Chronic viral hepatitis
Online Access:	https://eprints.nottingham.ac.uk/39968/

Similar Items

Hip fracture risk in patients with alcoholic cirrhosis: a population-based study using English and Danish data
by: Otete, Harmony E., et al.
Published: (2018)

Liver cirrhosis in England--an observational study: are we measuring its burden occurrence correctly?
by: Ratib, Sonia, et al.
Published: (2017)

Cytotoxicity of Goniothalamin on the Human Hepatocellular Carcinoma HEPG2 Cell Line
by: Obaid Al-Qubaisi, Mothanna Sadiq
Published: (2009)

Development and application of the antigen microarray for the detection of autoantibodies in hepatocellular carcinoma patients
by: Afriyie-Asante, Afrakoma
Published: (2019)

Causes of death in people with liver cirrhosis in England compared to the general population: a population-based cohort study
by: Ratib, Sonia, et al.
Published: (2015)

Host genetic factors associated with hepatocellular carcinoma in patients with hepatitis C virus infection: a systematic review
by: Walker, Alex J., et al.
Published: (2018)

Sex and age differences in the early identification and treatment of alcohol use: a population-based study of patients with alcoholic cirrhosis
by: Otete, Harmony E., et al.
Published: (2015)

Screening for hepatocellular carcinoma: patient selection and perspectives
by: Fateen, Waleed, et al.
Published: (2017)

Iron and Hepatic Carcinogenesis
by: Tirnitz-Parker, Janina, et al.
Published: (2013)

Effects of thymoquinone and thymoquinone-loaded nanostructured lipid carrier on hepatocellular carcinoma cell models, Hep3B and HepG2
by: Haron, Aminah Suhaila
Published: (2017)

Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Fateen, Waleed, et al.
Published: (2017)

Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3
by: Subramaniam, A., et al.
Published: (2013)

1 and 5 year survival estimates for people with cirrhosis of the liver in England, 1998–2009: a large population study
by: Ratib, Sonia, et al.
Published: (2014)

Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma
by: Subramaniam, A., et al.
Published: (2012)

Negative regulation of signal transducer and activator of transcription-3 signalling cascade by lupeol inhibits growth and induces apoptosis in hepatocellular carcinoma cells
by: Siveen, K., et al.
Published: (2014)

Obesity and type 2 diabetes are important risk factors underlying previously undiagnosed cirrhosis in general practice: a cross-sectional study using Transient Elastography
by: Harman, David J., et al.
Published: (2018)

The effects of probiotics and symbiotics on risk factors for hepatic encephalopathy
by: Viramontes Hörner, Daniela, et al.
Published: (2017)

Outcomes after successful direct acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis
by: Cheung, Michelle C.M., et al.
Published: (2016)

The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1-infected patients who do or do not achieve sustained virological response to therapy
by: Backx, M., et al.
Published: (2014)

Hepatic elastin content is predictive of adverse outcome in advanced fibrotic liver disease
by: Kendall, Timothy, et al.
Published: (2018)

Hepatitis B status in migrants and refugees: increasing health burden in Western Australia
by: Subramaniam, K., et al.
Published: (2011)

Alcohol consumption and health status of family members: Health impacts without ingestion
by: Liang, Wenbin, et al.
Published: (2013)

A validation study of the CirCom comorbidity score in an English cirrhosis population using the Clinical Practice Research Datalink
by: Crooks, Colin J., et al.
Published: (2018)

Development of surface plasmon resonance based assay for simultaneous detection of Hepatitis C and B viral infections
by: Akhavanrezaei, Morvarid
Published: (2015)

Quantitative magnetic resonance imaging to evaluate patients with liver cirrhosis
by: Scott, Robert A.D.
Published: (2020)

Targeted 5-fluorouracil-1-acetic acid delivery utilising cell penetrating peptide conjugated hepatitis b virus-like nanoparticles to squamous cell carcinoma A431
by: Gan, Bee Koon
Published: (2020)

All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study
by: Fleming, Kate M., et al.
Published: (2012)

Reduction in alcohol consumption and health status
by: Liang, Wenbin, et al.
Published: (2010)

Multi organ assessment of compensated cirrhosis patients using quantitative magnetic resonance imaging
by: Bradley, Christopher R., et al.
Published: (2018)

Opportunities in UK primary and secondary healthcare settings to prevent alcohol misuse
by: Otete, Harmony Eroboghene
Published: (2016)

Alcohol-attributable healthcare attendances up to 10 years prior to diagnosis of alcoholic cirrhosis: a population based case-control study
by: Otete, Harmony E., et al.
Published: (2016)

Caffeine and the analog CGS 15943 inhibit cancer cell growth by targeting the phosphoinositide 3-kinase/Akt pathway
by: Edling, C., et al.
Published: (2014)

Incidence and prevalence of celiac disease and dermatitis herpetiformis in the UK over two decades: population-based study
by: West, Joe, et al.
Published: (2014)

The incidence, prevalence and mortality of granulomatosis with polyangiitis in the UK Clinical Practice Research Datalink
by: Pearce, Fiona A., et al.
Published: (2016)

Antifibrotic Effect of Transforming Growth Factor Beta 1 Inhibitor Extract from Streptomyces SP.Strain H6552 on Human Hepatic Stellate Cells
by: Lim, Chooi Ling
Published: (2010)

Socioeconomic variation in the incidence of childhood coeliac disease in the UK
by: Zingone, Fabiana, et al.
Published: (2015)

Applications of phage peptide libraries for epitope discovery and identification of novel anti-virals
by: Hakami, Abdulrahim R.
Published: (2017)

The incidence, prevalence and survival of systemic sclerosis in the UK Clinical Practice Research Datalink
by: Royle, Jeremy G., et al.
Published: (2018)

Molecular epidemiology and antiviral resistance characterization of Hepatitis C virus circulating in Africa and Brazil
by: Adeboyejo, Kazeem Adeyinka
Published: (2020)

The identification of chronic liver disease in primary care using non-invasive diagnostics within a novel pathway
by: Harman, David J.
Published: (2017)